Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2011 1
2014 1
2016 3
2017 5
2018 2
2019 2
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.
Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI investigator group. Nadarajah R, et al. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36737420 Free PMC article.

Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day m

…

Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%

…
The association of air pollutants exposure with subclinical inflammation and carotid atherosclerosis.
Oikonomou E, Lazaros G, Mystakidi VC, Papaioannou N, Theofilis P, Vogiatzi G, Chasikidis C, Fountoulakis P, Papakostantinou MA, Assimakopoulos MN, Barmparesos N, Tasios P, Kaski JC, Tousoulis D. Oikonomou E, et al. Int J Cardiol. 2021 Nov 1;342:108-114. doi: 10.1016/j.ijcard.2021.07.056. Epub 2021 Jul 31. Int J Cardiol. 2021. PMID: 34339768

Mean cIMT (Region 1: 0.93 0.24 mm; Region 2: 0.96 0.40 mm; Region 3: 0.94 0.39 mm; Region 4: 1.14 0.55 mm, p < 0.001), maximum cIMT (p < 0.001) as well as carotid plaque burden (Region 1: 13.3%; Region 2: 18.8%; Region 3: 22.4%; Region 4: 38.6%, p <

…

Mean cIMT (Region 1: 0.93 0.24 mm; Region 2: 0.96 0.40 mm; Region 3: 0.94 0.39 mm; Region 4: 1.14 0.55 mm, p < 0.001), maximum cIM

…
The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis.
Abbott TEF, Ahmad T, Phull MK, Fowler AJ, Hewson R, Biccard BM, Chew MS, Gillies M, Pearse RM; International Surgical Outcomes Study (ISOS) group. Abbott TEF, et al. Br J Anaesth. 2018 Jan;120(1):146-155. doi: 10.1016/j.bja.2017.08.002. Epub 2017 Nov 23. Br J Anaesth. 2018. PMID: 29397122 Free article.
Checklist exposure was associated with reduced mortality [odds ratio (OR) 0.49 (0.32-0.77); P<0.01], but no difference in complication rates [OR 1.02 (0.88-1.19); P=0.75]. ...Checklist exposure was associated with both reduced postoperative mortality [OR 0.75 (0. …
Checklist exposure was associated with reduced mortality [odds ratio (OR) 0.49 (0.32-0.77); P<0.01], but no difference in complica …
An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
Kalafat E, Prasad S, Birol P, Tekin AB, Kunt A, Di Fabrizio C, Alatas C, Celik E, Bagci H, Binder J, Le Doare K, Magee LA, Mutlu MA, Yassa M, Tug N, Sahin O, Krokos P, O'brien P, von Dadelszen P, Palmrich P, Papaioannou G, Ayaz R, Ladhani SN, Kalantaridou S, Mihmanli V, Khalil A. Kalafat E, et al. Am J Obstet Gynecol. 2022 Mar;226(3):403.e1-403.e13. doi: 10.1016/j.ajog.2021.09.024. Epub 2021 Sep 25. Am J Obstet Gynecol. 2022. PMID: 34582796 Free PMC article.
The 'full-COvid Maternal Intensive Therapy' model included body mass index (adjusted risk ratio, 1.39; 95% confidence interval, 1.07-1.95; P=.015), lower respiratory symptoms (adjusted risk ratio, 5.11; 95% confidence interval, 1.81-21.4; P=.007), neutrophil to lymp …
The 'full-COvid Maternal Intensive Therapy' model included body mass index (adjusted risk ratio, 1.39; 95% confidence interval, 1.07-1.95; …
Gastrointestinal motility following thoracic surgery: the effect of thoracic epidural analgesia. A randomised controlled trial.
Zoumprouli A, Chatzimichali A, Papadimitriou S, Papaioannou A, Xynos E, Askitopoulou H. Zoumprouli A, et al. BMC Anesthesiol. 2017 Oct 16;17(1):139. doi: 10.1186/s12871-017-0427-y. BMC Anesthesiol. 2017. PMID: 29037157 Free PMC article. Clinical Trial.

The OCTT test revealed statistically significant differences between all groups (Ep-R vs Ep-RM, p = 0.43/Ep-R vs IV-M, p = 0.039 / Ep-RM vs IV-M, p < 0.001). Also, very significant differences were found in the OCCT test between days (Ep-R vs Ep-RM, p

…
The OCTT test revealed statistically significant differences between all groups (Ep-R vs Ep-RM, p = 0.43/Ep-R vs IV-M, p = 0.0 …
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Diamantopoulos PT, Symeonidis A, Pappa V, Kotsianidis I, Galanopoulos A, Pontikoglou C, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Repousis P, Kotsopoulou M, Dimou M, Solomou E, Dryllis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kyrtshonis MC, Kourakli A, Papadaki H, Panayiotidis P, Viniou NA. Diamantopoulos PT, et al. Br J Haematol. 2021 Mar;192(6):978-987. doi: 10.1111/bjh.17062. Epub 2020 Aug 30. Br J Haematol. 2021. PMID: 32862447 Free article.
Delays during the first two cycles were noted in 150 patients (16.7%) and were found to adversely affect OS(T) independently of the International Prognostic Scoring System score [hazard ratio (HR), 1.368; P = 0.033] or pre-existing neutropenia (HR, 1.42; P = 0.015). …
Delays during the first two cycles were noted in 150 patients (16.7%) and were found to adversely affect OS(T) independently of the Internat …
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system.
Diamantopoulos PT, Kotsianidis I, Symeonidis A, Pappa V, Galanopoulos A, Gogos D, Karakatsanis S, Papadaki H, Palla A, Hatzimichael E, Dimou M, Papageorgiou S, Delimpasis S, Papaioannou M, Papoutselis M, Kourakli A, Tsokanas D, Anagnostopoulos A, Kontos CK, Panayiotidis P, Viniou NA; Hellenic MDS study group. Diamantopoulos PT, et al. Leuk Lymphoma. 2019 Jul;60(7):1721-1730. doi: 10.1080/10428194.2018.1540783. Epub 2018 Nov 14. Leuk Lymphoma. 2019. PMID: 30424699

Out of the seven most widely used prognostic scoring systems for CMML, the Dusseldorf score (DUSS) showed the best prognostic capability (HR, 2.27; p < .001). Forty-one (48.8%) patients progressed to acute myeloid leukemia (AML) after a median time of 15.2 months follow

…
Out of the seven most widely used prognostic scoring systems for CMML, the Dusseldorf score (DUSS) showed the best prognostic capability (HR …
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
Diamantopoulos PT, Pappa V, Symeonidis A, Kotsianidis I, Galanopoulos A, Papadaki H, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Kotsopoulou M, Repousis P, Dimou M, Solomou E, Pontikoglou C, Kyriakakis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kourakli A, Panayiotidis P, Viniou NA. Diamantopoulos PT, et al. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):114-121. doi: 10.1016/j.clml.2019.09.614. Epub 2019 Sep 28. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31884152
We divided patients, on the basis of their survival after 5-azacytidine initiation (OS(T)), in groups of long-term survivors (Q(3) and P(90) group with OS(T) above the third quartile and the 90th percentile of the whole group, respectively) and short-term survivors compris …
We divided patients, on the basis of their survival after 5-azacytidine initiation (OS(T)), in groups of long-term survivors (Q(3) and P …
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.
Zarifis J, Grammatikou V, Kallistratos M, Katsivas A. Zarifis J, et al. Angiology. 2017 Jan;68(1):10-18. doi: 10.1177/0003319716630499. Epub 2016 Mar 8. Angiology. 2017. PMID: 26960667 Free PMC article.

After ivabradine administration, mean number of anginal events decreased from 2.2 2.3 (median: 2.0, minimum: 0.0, maximum: 21.0, range: 21.0) to 0.3 0.6 (median: 0.0, minimum: 0.0, maximum: 7.0, range: 7.0) times/week (P < .001), while nitroglycerin consumption decrease

…
After ivabradine administration, mean number of anginal events decreased from 2.2 2.3 (median: 2.0, minimum: 0.0, maximum: 21.0, range: 21.0 …
17 results